Dollars and stents: A brave new world
- PMID: 28488405
- DOI: 10.1002/ccd.27077
Dollars and stents: A brave new world
Abstract
Reimbursement in the healthcare system is shifting from pure volume to a mixed volume/value-based metric. Using complex statistical modeling to adjust for unknowns, the study provides real world data that the use of Co-Cr EES is more cost effective than BMS assuming that clinicians select clopidogrel for P2Y12 inhibition. More cost-effectiveness analyses should be conducted to guide the use of ever costlier novel medical devices and drugs.
© 2017 Wiley Periodicals, Inc.
Comment on
-
Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.Catheter Cardiovasc Interv. 2017 May;89(6):994-1002. doi: 10.1002/ccd.26700. Epub 2016 Aug 16. Catheter Cardiovasc Interv. 2017. PMID: 27527508 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
